Improved quantification of neutrophil activity in serum is achieved by measuring calprotectin metabolites
A novel serum calprotectin assay (CPa9-HNE) has been developed, which quantifies neutrophil activity and correlates with disease activity in patients with Crohn’s disease and ulcerative colitis.
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in
